MicroHealth (Accelerator)

Company Description: Today, biopharma companies don't know how their products work for each individual user. Even after investing billions in R&D to measure the performance of medicines in randomized controlled clinical trials, our biopharma clients (Sanofi, Roche, Novo Nordisk, Bayer, and Biogen) still can't predict how the outcomes from those generic cohorts will translate to a particular person. MicroHealth supercharges biopharma to track, predict & improve INDIVIDUAL TREATMENT JOURNEYS. Our digital health platform has three core components: 1. Patient apps: Consumers use our disease-specific mobile apps to track the trajectory of their care plan and to stay connected with their HCPs outside the clinic. 2. Provider portal: Clinicians use our online portal for remote monitoring and to make evidence-based adjustments based on how the treatment evolves. 3. Pharma AI engine: Enterprise clients leverage our de-identified dataset of patient reported outcomes to predict and improve individual treatment journeys. MicroHealth is the world’s leading digital hemophilia platform. We currently have a 35% market share in the US hemophilia market. Our product is clinically validated in peer reviewed publications (American Journal of Hematology) and is linked to a 57% improvement in health outcomes.